KM02894 is a glutamate release inhibitor. Cancer cells release high levels of glutamate that can disrupt normal bone turnover, which can lead to cancer-induced bone pain.KM02894 may be used in the study of tumor-related diseases.
Molecular Weight:
215.3
CAS Number:
[116850-74-9]
Formula:
C7H9N3OS2
Target:
GluR
* VAT and and shipping costs not included. Errors and price changes excepted
